Pushpa M Jairam1, Yolanda van der Graaf2, Jan-Willem J Lammers3, Willem P Th M Mali4, Pim A de Jong4. 1. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands. 2. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. 3. Department of Pulmonology, University Medical Center Utrecht, Utrecht, The Netherlands. 4. Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Abstract
BACKGROUND: This study aimed to evaluate whether incidental CT findings of emphysema, airway thickening and bronchiectasis, as seen on CT scans performed for other non-pulmonary clinical indications, are associated with future acute exacerbations of COPD resulting in hospitalisation or death. METHODS: This multicentre prospective case-cohort study comprised 6406 subjects who underwentroutine diagnostic chest CTfor non-pulmonary indications. Using a case-cohort approach, we visually graded CT scans from cases and a random sample of ∼10% of the baseline cohort (n=704) for emphysema severity (range 0-20), airway thickening (range 0-5) and bronchiectasis (range 0-5). We used weighted Cox proportional hazards analysis to assess the independent association between CT findings and hospitalisation or death due to COPD exacerbation. RESULTS: During a median follow-up of 4.4 years (maximum 5.2 years), 338 COPD events were identified. The risk of experiencing a future acute exacerbation of COPD resulting in hospitalisation or death was significantly increased in subjects with severe emphysema (score ≥7) and severe airway thickening (score ≥3). The respective HRs were 4.6 (95% CI 3.0 to 7.1) and 5.9 (95% CI 3.4 to 10.5). Severe bronchiectasis (score ≥3) was not significantly associated with increased risk of adverse events (HR 1.5; 95% CI 0.9 to 2.5). CONCLUSIONS: Morphological correlates of COPD such as emphysema and airway thickening detected on CT scans obtained for other non-pulmonary indications are strong independent predictors of subsequent development of acute exacerbations of COPD resulting in hospitalisation or death. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
RCT Entities:
BACKGROUND: This study aimed to evaluate whether incidental CT findings of emphysema, airway thickening and bronchiectasis, as seen on CT scans performed for other non-pulmonary clinical indications, are associated with future acute exacerbations of COPD resulting in hospitalisation or death. METHODS: This multicentre prospective case-cohort study comprised 6406 subjects who underwent routine diagnostic chest CT for non-pulmonary indications. Using a case-cohort approach, we visually graded CT scans from cases and a random sample of ∼10% of the baseline cohort (n=704) for emphysema severity (range 0-20), airway thickening (range 0-5) and bronchiectasis (range 0-5). We used weighted Cox proportional hazards analysis to assess the independent association between CT findings and hospitalisation or death due to COPD exacerbation. RESULTS: During a median follow-up of 4.4 years (maximum 5.2 years), 338 COPD events were identified. The risk of experiencing a future acute exacerbation of COPD resulting in hospitalisation or death was significantly increased in subjects with severe emphysema (score ≥7) and severe airway thickening (score ≥3). The respective HRs were 4.6 (95% CI 3.0 to 7.1) and 5.9 (95% CI 3.4 to 10.5). Severe bronchiectasis (score ≥3) was not significantly associated with increased risk of adverse events (HR 1.5; 95% CI 0.9 to 2.5). CONCLUSIONS: Morphological correlates of COPD such as emphysema and airway thickening detected on CT scans obtained for other non-pulmonary indications are strong independent predictors of subsequent development of acute exacerbations of COPD resulting in hospitalisation or death. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Anthony J Esposito; Jeffrey A Sparks; Ritu R Gill; Hiroto Hatabu; Eric J Schmidlin; Partha V Hota; Sergio Poli; Elaine A Fletcher; Wesley Xiong; Michelle L Frits; Christine K Iannaccone; Maria Prado; Alessandra Zaccardelli; Allison Marshall; Paul F Dellaripa; Michael E Weinblatt; Nancy A Shadick; Ivan O Rosas; Tracy J Doyle Journal: Rheumatology (Oxford) Date: 2022-08-03 Impact factor: 7.046
Authors: Elizabeth C Oelsner; J Jeffrey Carr; Paul L Enright; Eric A Hoffman; Aaron R Folsom; Steven M Kawut; Richard A Kronmal; David J Lederer; Joao A C Lima; Gina S Lovasi; Benjamin M Smith; Steven J Shea; R Graham Barr Journal: Thorax Date: 2016-04-05 Impact factor: 9.139
Authors: James D Chalmers; Stefano Aliberti; Eva Polverino; Montserrat Vendrell; Megan Crichton; Michael Loebinger; Katerina Dimakou; Ian Clifton; Menno van der Eerden; Gernot Rohde; Marlene Murris-Espin; Sarah Masefield; Eleanor Gerada; Michal Shteinberg; Felix Ringshausen; Charles Haworth; Wim Boersma; Jessica Rademacher; Adam T Hill; Timothy Aksamit; Anne O'Donnell; Lucy Morgan; Branislava Milenkovic; Leandro Tramma; Joao Neves; Rosario Menendez; Perluigi Paggiaro; Victor Botnaru; Sabina Skrgat; Robert Wilson; Pieter Goeminne; Anthony De Soyza; Tobias Welte; Antoni Torres; J Stuart Elborn; Francesco Blasi Journal: ERJ Open Res Date: 2016-01-20
Authors: Joshua Gawlitza; Frederik Trinkmann; Hans Scheffel; Andreas Fischer; John W Nance; Claudia Henzler; Nils Vogler; Joachim Saur; Ibrahim Akin; Martin Borggrefe; Stefan O Schoenberg; Thomas Henzler Journal: Can Respir J Date: 2018-03-04 Impact factor: 2.409
Authors: Kristoffer Ostridge; Nicholas Williams; Viktoriya Kim; Stephen Harden; Simon Bourne; Ngaire A Coombs; Paul T Elkington; Raul San Jose Estepar; George Washko; Karl J Staples; Tom M A Wilkinson Journal: Respir Res Date: 2016-07-26